Co-Promotion Alliance Relationships

Otsuka has a number of Global Co-Promotion relationships around the world. We value these relationships and the ability to leverage the strengths and expertise of various pharmaceutical companies, with one common goal in mind: creating new products for better health worldwide.

logo

In Canada, OCPI co-promotes the Abilify (tablet) with Bristol Myers Squibb Canada Co. (“BMS Canada”).

BMS Canada has been in operation for over eighty years and is a subsidiary of the New York-based multinational, Bristol-Myers Squibb (NYSE: BMY), focusing on research and development of innovative treatments in a number of areas, one of which is neuroscience.

 

lundbeck

OCPI recently launched Abilify MaintenaTM (injectable) with Lundbeck Canada Inc. (“Lundbeck Canada”).

Lundbeck Canada has been in operation for close to two decades and is a subsidiary of H. Lundbeck A/S, also focusing on research and development in the area of neuroscience. 


Contact Us

1 888 997-9017
514 332-3001

Location
2250 Alfred-Nobel Boulevard,
St-Laurent, Quebec,
Suite 301
H4S 2C9


Legal